share_log

Truist Securities Maintains Hold on Inari Medical, Lowers Price Target to $52

Truist Securities Maintains Hold on Inari Medical, Lowers Price Target to $52

Truist Securities繼續持有Inari Medical,將目標股價下調至52美元
Moomoo 24/7 ·  03/22 09:08

Truist Securities analyst Richard Newitter maintains Inari Medical (NASDAQ:NARI) with a Hold and lowers the price target from $61 to $52.

Truist Securities分析師理查德·紐特維持伊納裏醫療(納斯達克股票代碼:NARI)的持倉並將目標股價從61美元下調至52美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論